DENVER, Colo., Nov 05, 2025 (247marketnews.com)- Markets open this morning amid a flurry of innovation-led headlines spanning biotech, sustainable materials, and digital energy.
Lunai Bioworks (NASDAQ:LNAI) soared in early trading after announcing that its next-generation immune cell therapy achieved complete regression of both primary and metastatic pancreatic tumors in humanized models, a rare feat in one of medicine’s deadliest cancers. Published November 2 in Vaccines, the peer-reviewed report marks a major step toward clinical readiness for the company’s second-generation, allogeneic dendritic cell therapy. CEO David Weinstein called it “an important inflection point” as Lunai moves from research innovation to clinical translation. Investors view the findings as potential validation of Lunai’s AI-driven approach to biodefense and oncology, positioning the company at the forefront of next-generation immunotherapy.
Kraig Biocraft Laboratories (OTCQB:KBLB) is spinning market excitement of its own, preparing to deliver its first commercial spider silk fiber and fabric samples to partners in performance apparel and luxury textiles. These shipments, typically 50 to 500 kilograms each, signal true production scale and the company’s transition from R&D to revenue. Spider silk, five times stronger than steel by weight yet fully biodegradable, could redefine the $6.5 billion sustainable textile market. 24/7 Market News dubbed it “the official start of the spider silk race,” with Kraig Labs in pole position.
In M&A news, Cheer Holding (NASDAQ:CHR) revealed it has received two non-binding acquisition proposals from Zhongsheng Dingxin Investment Fund Management and Excel Ally Ventures, offering $0.56 and $0.52 per share, respectively. The board is forming a special committee to evaluate both bids and other strategic alternatives.
RedHill Biopharma (NASDAQ:RDHL) added fuel to the biotech momentum after securing a final $10.5 million judgment win in New York Supreme Court against Kukbo Co. Ltd., now enforceable and accruing 9% statutory interest.
Elsewhere, Beyond Air (NASDAQ:XAIR) extended its cash runway through 2027 after securing up to $32 million in new financing from Streeterville Capital, supporting commercial growth of its LungFit PH device.
In tech-bio, Recursion (NASDAQ:RXRX) impressed the market after hitting a $30 million milestone payment from Roche & Genentech for delivering its second microglia “neuro map,” bringing total partnership proceeds above $500 million. With nearly $785 million in cash and runway through 2027, Recursion continues to prove that AI-powered drug discovery can be both scalable and profitable.
Rounding out the morning, MetaVia (NASDAQ:MTVA) will present new Phase 1 and pre-clinical data for its obesity drug DA-1726 at ObesityWeek 2025, showing promising once-weekly dosing and clinically meaningful weight loss comparable to leading GLP-1 competitors.
Traders are also keeping a close eye on Nuvve Holding (NASDAQ:NVVE), up sharply after its $4.8 million offering and pivot toward digital assets, and MMTec (NASDAQ:MTC), which faces imminent delisting from Nasdaq following non-compliance rulings.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
Contact [email protected] for Analyst Report coverage and other investor/public relations services.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
The post AI Breakthroughs, Biotech Wins, and a Spider Silk Revolution appeared first on 24/7 MarketNews.
